Guy’s and St Thomas’ NHS Foundation Trust is teaming up with healthcare logistics firm Apian and Alphabet’s drone subsidiary, Wing, to launch a new medical drone delivery service in London. The initiative aims to streamline the transportation of urgent pathology items—such as blood samples—between hospitals, potentially improving patient care by reducing delivery times and carbon emissions.
Set to begin in autumn 2024, the trial service will see electric drones ferry blood samples between Guy’s Hospital and the lab at St Thomas’ Hospital. This switch will cut transport times from over 30 minutes by road to less than two minutes by air, a critical improvement for patients undergoing surgery, particularly those with bleeding disorders, where swift analysis is essential.
Efficiency and Sustainability in Healthcare
Currently, blood samples are transported by motorbikes and vans. Moving to electric drones represents a significant step towards reducing the NHS's environmental footprint. According to Apian, these lightweight drones could cut CO2 emissions by up to 99% compared to traditional vehicles and even surpass electric vans in energy efficiency. In a densely populated city like London, reducing road congestion while cutting emissions aligns with wider efforts to create a more sustainable healthcare system.
The trial will run for six months under the oversight of the UK Civil Aviation Authority (CAA), which has granted airspace approval for the operation. While Apian has successfully tested medical drone deliveries in rural UK areas and Dublin, Ireland, this marks the first deployment of such a service in London.
Optimizing Healthcare Delivery
Professor Ian Abbs, Chief Executive at Guy’s and St Thomas’, sees the trial as part of the Trust’s broader effort to modernize healthcare delivery. "This drone pilot combines two of our key priorities—providing the best possible patient care and improving sustainability," he said. "We are proud to be the first Trust in London to trial this innovative approach to help speed up blood sample analysis for our most urgent cases."
The project has also gained support from London’s leadership. Howard Dawber, Deputy Mayor of London for Business and Growth, highlighted the collaboration as an example of how London-based startups can address major public health challenges through technological innovation. "This new service shows how London is leading the way in improving healthcare as we build a fairer London for all," Dawber noted.
Safe Integration of Drones in Healthcare
Sophie O’Sullivan, Director of Future of Flight at the CAA, emphasized that this trial illustrates the growing potential for drones in practical, everyday applications. "Innovative trials like this help demonstrate the many positive and safe ways that drones can be used for society," she said. The CAA’s involvement in such trials reflects its commitment to enabling new aviation technologies while ensuring public safety.
For Apian, this trial is a significant step toward integrating drones into the NHS’s broader logistics framework. "Drones can increase the responsiveness and resilience of healthcare logistics, allowing clinicians to be more productive and patients to get the care they need sooner," said Dr. Hammad Jeilani, Co-Founder of Apian. "An NHS drone delivery network in London, starting with this trial, will provide on-demand, automated, and sustainable deliveries, helping the NHS create more efficient models of working."
A Forward-Looking Approach to Medical Logistics
As the trial begins, it signals a shift in how medical supplies might be delivered in urban settings. If successful, the model could be adopted more widely across other NHS trusts, offering an efficient, sustainable, and scalable approach to healthcare logistics. While drones have long been viewed as a futuristic solution, their role in improving the practicalities of everyday medical logistics may soon become a reality in London’s skies.
This partnership showcases a measured approach to modernizing healthcare delivery, with potential benefits for both patients and the environment.